Use of melanotan I and II in the general population

被引:40
作者
Evans-Brown, Michael [1 ]
Dawson, Rob T. [2 ]
Chandler, Martin [1 ]
McVeigh, Jim [1 ]
机构
[1] Liverpool John Moores Univ, Fac Hlth & Appl Social Sci, Ctr Publ Hlth, Liverpool L3 2AY, Merseyside, England
[2] Drugs Sport Clin & Users Support, Rowlands Gill NE39 1DU, Tyne & Wear, England
来源
BRITISH MEDICAL JOURNAL | 2009年 / 338卷
关键词
RECEPTORS;
D O I
10.1136/bmj.b566
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 13 条
[1]  
*CLIN PHARM LTD, 2008, ANN REP 2008
[2]  
*DAN MED AUTH, 2008, WARN PROD MEL
[3]  
Dorr RT, 2000, PHOTOCHEM PHOTOBIOL, V72, P526, DOI 10.1562/0031-8655(2000)072<0526:IEEATI>2.0.CO
[4]  
2
[5]  
EVANS-BROWN M., 2008, SportEX Medicine, V38, P20
[6]   Melanocortin peptide therapeutics: Historical milestones, clinical studies and commercialization [J].
Hadley, ME ;
Dorr, RT .
PEPTIDES, 2006, 27 (04) :921-930
[7]  
MCCARTHY W, 2002, WIRED 0610
[8]  
Medicines and Healthcare products Regulatory Agency, 2008, TAN JAB IS UNL MED M
[9]  
*NORW MED AG, 2008, LEG ADV MOT BRUK MEL
[10]  
*PAL TECHN INC, BREM ORG PROT REL IN